PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97518585 |
Filing Date: 07/25/2022 |
Input Field |
Entered |
SERIAL NUMBER | 97518585 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\975\185\97518585\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | DYNAVAX |
COLOR MARK | NO |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the word "DYNAVAX" in stylized lettering. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 942 x 250 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Dynavax Technologies Corporation |
*MAILING ADDRESS | 2100 Powell Street, Suite 720 |
*CITY | Emeryville |
*STATE (Required for U.S. applicants) |
California |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
94608 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Medical, scientific, pharmaceutical, and biological research, testing and product development consultation; medical, scientific, pharmaceutical, and biological research, testing and product development for others; medical, scientific, pharmaceutical, biological, vaccine, and vaccine adjuvant research and development |
FILING BASIS | SECTION 1(b) |
ADDITIONAL STATEMENTS SECTION | |
ACTIVE PRIOR REGISTRATION(S) | The applicant claims ownership of active prior U.S. Registration Number(s) 3366555, 3307735, and 5151687. |
ATTORNEY INFORMATION | |
NAME | Beth M. Goldman |
ATTORNEY DOCKET NUMBER | 21557-1 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Orrick, Herrington & Sutcliffe LLP |
INTERNAL ADDRESS | IP Prosecution Department |
STREET | 2050 Main Street, Suite 1100 |
CITY | Irvine |
STATE | California |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 92614-8255 |
PHONE | 415-773-5700 |
FAX | 949-567-6710 |
EMAIL ADDRESS | ipprosecutionsf@orrick.com |
OTHER APPOINTED ATTORNEY | Betsy Wang Lee, Ashlie J. Smith, Seth Reagan, Kristin S. Cornuelle, Diana M. Rutowski, Robert M. O'Connell Jr., Lindsay Rindskopf, Katherine Kerrick |
CORRESPONDENCE INFORMATION | |
NAME | Beth M. Goldman |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | ipprosecutionsf@orrick.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | beth.goldman@orrick.com; blee@orrick.com; ashlie.smith@orrick.com; aparker@orrick.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Alex Oh/ |
SIGNATORY'S NAME | Alex Oh |
SIGNATORY'S POSITION | Vice President, IP and Associate General Counsel |
SIGNATORY'S PHONE NUMBER | 415-773-5700 |
DATE SIGNED | 07/25/2022 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97518585 |
Filing Date: 07/25/2022 |
The applicant's current Correspondence Information: |
Beth M. Goldman |
PRIMARY EMAIL FOR CORRESPONDENCE: ipprosecutionsf@orrick.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): beth.goldman@orrick.com; blee@orrick.com; ashlie.smith@orrick.com; aparker@orrick.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|